Member Info for Jarv55

We submitted our test a few weeks ago don't think that test has CE marking either.

Let this sink in this is without FDA approval.
Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.
Imagine what the demand will be like on approval.

https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories/wuhan-novel-coronavirus-who-to-call-to-request-laboratory-testing

https://twitter.com/WalesOnline/status/1229725692411203585
Hospital closing.

Read the last line the Ce mark was important.
As previously announced, the Company has submitted an application to, and remains in discussion with, the US Food and Drug Administration (FDA) for Emergency Use Approval (EUA) of its test for COVID-19, which would allow laboratories in the US to use the test for clinical diagnosis on a temporary basis. The data generated from the CE-Mark approval will be used to support this application.

Look at the volume

Look at France and then look here this is mms short of stock

Latino last time I saw manipulation like this was RKH

Nice cheap top ups see you all at £3

Sparrow you numpty they are filling orders

There will be lots of shakes along the way.

Lets get these warrants out of the way
https://www.lse.co.uk/rns/NCYT/new-term-loan-and-termination-of-bond-facility-29ueuq11bw4h9ht.html

Actually disagree think there are plenty in from the lows. Some have averaged up.

https://www.dailymail.co.uk/money/markets/article-8013587/Shares-biotechnology-firm-Novacyt-rocket-record-high-launches-test-coronavirus.html

This is just the start
https://twitter.com/Simon94957586/status/1229489729361584128/photo/1

Anyway a great post from advfn, sums up well the gems in today Rns:

TheAppleFreak
17 Feb '20 - 16:28 - 1061 of 1186
0 1 0
Why would we need placing when we are in a super strong position!

First CE-Marked test for 2019 strain of COVID-19.
Test used by researchers, hospitals and does not require validation by a clinician.
Company anticipating increased demand due to its extended use in clinical diagnosis.
Already taken 288,000 requests quotes for the CE-Mark test announced on 14th Feb.. That's only 2 NON WORKING DAYS.
Already on paper is order for 35,000 of the older RUO tests.
Demand for the tests has come from China! US! UK! and many more!
High conversion rate of quotes to orders.
Since the start of the spread the company has invested in manufacturing to meet current and potential further demand.
CE-Mark is currently being evaluated by varies public health organizations, company actively talking to these to support their screening efforts.
Pending approval with FDA with current data being supplied on a regular basis to aid the approval.
DYOR but you can't talk this down.

Things missing here Nasdaq listing
possible JV
Maybe a buy out.

Yea well a few want in

Err no thanks I will wait for FDA approval

The Company continues to see a high conversion rate from quotations to orders. However, it is difficult to predict how demand for the test will grow as the epidemic is still in its early stages. Since the initial reports of COVID-19, the Company has invested in manufacturing capacity to meet the current and potential future demand for its tests.

Who are the manufacturers supporting them? Thermal Fisher?

FDA approval opens the flood gates.